Skip to main content
Professional Technical IVT

proopiomelanocortin

Pronunciation: /ˌproʊoʊpaɪoʊˌmɛlənoʊˈkɔrtɪn/

Also written as: POMC — Proopiomelanocortin

A large precursor polypeptide that undergoes post-translational processing to yield multiple bioactive peptides including ACTH, β-endorphin, and melanocyte-stimulating hormones.

Full Definition

Proopiomelanocortin (POMC) is a 267-amino acid precursor polypeptide synthesized primarily in the anterior pituitary corticotrophs and hypothalamic arcuate nucleus neurons. Through tissue-specific enzymatic cleavage by prohormone convertases, POMC generates several important bioactive peptides including adrenocorticotropic hormone (ACTH), β-endorphin, and various melanocyte-stimulating hormones (α-, β-, and γ-MSH). In the pituitary, POMC processing primarily yields ACTH and β-endorphin, while in the hypothalamus, further processing produces melanocortins involved in appetite regulation and energy homeostasis. POMC neurons are key regulators of the hypothalamic-pituitary-adrenal axis and feeding behavior.

Usage

Usage note: Note the distinction from 'pro-opiomelanocortin' - proopiomelanocortin is the full precursor form.

In Context

  • "The patient exhibited a proopiomelanocortin gene mutation resulting in severe early-onset obesity." — Genetic consultation report
  • "Proopiomelanocortin processing was abnormal in the pituitary adenoma specimen." — Pathology report

Also known as

POMC precursor pro-opiomelanocortin precursor

Don't confuse with

pro-opiomelanocortin melanocortin

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON